Terug
43
Dagbereik
€ 474,91
€ 493,22
52-Weeksbereik
€ 314,43
€ 556,52
Volume
1.154.116
50D / 200D Gem.
€ 508,95
/
€ 443,17
Vorige Slotkoers
€ 494,58
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 16,0 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 9,0 | 3,8 |
| Rev Growth 5Y % | 6,5 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 523,92
+7.9%
Low: € 425,00
High: € 635,00
Forward K/W
16,3
Forward WPA
€ 30,27
WPA Groei (sch.)
+0,0%
Omzet Sch.
79 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 49,36
€ 48,21 – € 50,93
|
100 B | 5 |
| FY2029 |
€ 42,58
€ 41,58 – € 43,93
|
93 B | 2 |
| FY2028 |
€ 37,30
€ 35,61 – € 38,71
|
87 B | 7 |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 11, 2026 |
Berres Jennifer
SVP & Chief Human Res. Officer
|
sell | 8.020 | € 503,00 | € 4.126.950 |
| Feb 10, 2026 |
Berres Jennifer
SVP & Chief Human Res. Officer
|
grant | 7.116 | — | — |
| Feb 10, 2026 |
Berres Jennifer
SVP & Chief Human Res. Officer
|
other | 2.515 | € 502,05 | € 1.262.656 |
| Feb 6, 2026 |
Elcan Patricia F
|
other | 73.186.329 | — | — |
| Feb 6, 2026 |
FRIST THOMAS F III
|
other | 73.186.329 | — | — |
| Feb 6, 2026 |
Frist William R
|
other | 73.186.329 | — | — |
| Feb 6, 2026 |
HERCULES HOLDING II
|
other | 36.629.188 | — | — |
| Feb 6, 2026 |
Frisco Holding II
|
other | 73.186.329 | — | — |
| Feb 6, 2026 |
FRIST THOMAS F JR
|
other | 73.186.329 | — | — |
| Feb 4, 2026 |
HAZEN SAMUEL N
CEO
|
other | 2.090 | € 498,35 | € 1.041.552 |
| Feb 3, 2026 |
HAZEN SAMUEL N
CEO
|
sell | 42.877 | € 502,95 | € 21.483.275 |
| Jan 29, 2026 |
Marks Mike A
EVP and CFO
|
grant | 11.945 | — | — |
| Jan 29, 2026 |
McAlevey Michael R
EVP & Chief Legal & Admin Off.
|
grant | 8.067 | — | — |
| Oct 31, 2025 |
HAZEN SAMUEL N
CEO
|
other | 144.273 | € 69,58 | — |
| May 13, 2025 |
Foster Jon M
EVP and COO
|
sell | 15.698 | € 369,32 | € 5.797.661 |
| May 13, 2025 |
Foster Jon M
EVP and COO
|
other | 38.160 | — | — |
| Apr 30, 2025 |
Frist William R
|
other | 10.505 | € 340,60 | € 3.578.003 |
| Apr 29, 2025 |
Frist William R
|
grant | 1.026 | — | — |
| Apr 29, 2025 |
FRIST THOMAS F III
|
grant | 1.320 | — | — |
| Apr 29, 2025 |
Dennis Robert J
|
grant | 1.026 | — | — |
Belangrijkste Punten
Revenue grew 6,51% annually over 5 years — modest growth
Earnings grew 17,78% over the past year
Generating 7,69B in free cash flow
PEG of 0,56 suggests growth is underpriced
Cash machine — converts 113,38% of earnings into free cash flow
Capital efficient — spends only 6,54% of revenue on capex
Groei
Revenue Growth (5Y)
6,51%
Revenue (1Y)7,08%
Earnings (1Y)17,78%
FCF Growth (3Y)28,11%
Kwaliteit
Return on Equity
N/A
ROIC20,32%
Net Margin8,97%
Op. Margin15,83%
Veiligheid
Debt / Equity
N/A
Current Ratio0,83
Interest Coverage5,32
Waardering
P/E Ratio
16,01
P/B RatioN/A
EV/EBITDA13,19
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,08% | Revenue Growth (3Y) | 7,87% |
| Earnings Growth (1Y) | 17,78% | Earnings Growth (3Y) | 13,76% |
| Revenue Growth (5Y) | 6,51% | Earnings Growth (5Y) | -0,62% |
| Profitability | |||
| Revenue (TTM) | 75,60B | Net Income (TTM) | 6,78B |
| ROE | N/A | ROA | 11,17% |
| Gross Margin | 41,50% | Operating Margin | 15,83% |
| Net Margin | 8,97% | Free Cash Flow (TTM) | 7,69B |
| ROIC | 20,32% | FCF Growth (3Y) | 28,11% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,83 |
| Interest Coverage | 5,32 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 16,01 | P/B Ratio | N/A |
| P/S Ratio | 1,44 | PEG Ratio | 0,56 |
| EV/EBITDA | 13,19 | Dividend Yield | 0,01% |
| Market Cap | 108,62B | Enterprise Value | 157,78B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 75,60B | 70,60B | 64,97B | 60,23B | 58,75B |
| Net Income | 6,78B | 5,76B | 5,24B | 5,64B | 6,96B |
| EPS (Diluted) | 28,38 | 22,00 | 18,96 | 19,15 | 21,16 |
| Gross Profit | 31,37B | 28,68B | 25,58B | 23,18B | 22,49B |
| Operating Income | 11,97B | 10,55B | 9,63B | 9,05B | 9,68B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 60,72B | 59,51B | 56,21B | 52,44B | 50,74B |
| Total Liabilities | 63,49B | 58,96B | 55,15B | 52,51B | 49,25B |
| Shareholders' Equity | -6,03B | -2,50B | -1,77B | -2,77B | -933,00M |
| Total Debt | 50,20B | 45,24B | 41,86B | 40,20B | 36,73B |
| Cash & Equivalents | 1,04B | 1,93B | 935,00M | 908,00M | 1,45B |
| Current Assets | 13,56B | 16,41B | 14,93B | 13,64B | 13,54B |
| Current Liabilities | 16,35B | 15,18B | 12,66B | 9,90B | 9,58B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#228 of 332
Recente Activiteit
Ingestapt
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026